Tocilizumab Was Effective in Repairing the Large Geode in a Patient with Rheumatoid Arthritis

Figure 3

Transition of (a) erythrocyte sedimentation rate (ESR), (b) C-reactive protein (CRP), (c) matrix metalloproteinase (MMP)-3, and (d) disease activity score (DAS) 28. After visiting our department, the patient was treated with methotrexate. From August 22, 2016, the patient started to receive tocilizumab, and all laboratory data and DAS28 improved remarkably and immediately after administration.

(a)

(b)

(c)

(d)